Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Myeloid Leukemia (AML) Clinical Trial
NCT02391480 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 128 Participants

This is a Phase 1, first-in-human, dose escalation study in participants with advanced solid tumors to determine the pharmacokinetics, maximum tolerated dose and the recommended Phase 2 dose of ABBV-075 at different monotherapy dosing schedules. In addition the study will evaluate the safety. tolerability and the pharmacokinetics of ABBV-075 monotherapy or combination therapy in disease specific expansion cohorts.